Mocetinostat
Mocetinostat Uses, Dosage, Side Effects, Food Interaction and all others data.
Mocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others.
All HDAC inhibitors induce histone H3 hyperacetylation, correlating with inhibition of proliferation, induction of cell differentiation and apoptosis.
| Trade Name | Mocetinostat |
| Generic | Mocetinostat |
| Mocetinostat Other Names | Mocetinostat |
| Type | |
| Formula | C23H20N6O |
| Weight | Average: 396.454 Monoisotopic: 396.169859288 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Mocetinostat works
Mocetinostat is a novel isotypic-selective inhibitor of the enzyme histone deacetylase (HDAC). HDAC inhibitors act by turning on tumour suppressor genes that have been inappropriately turned off. Tumour suppressor genes are a natural defense against cancer. It is therefore hypothesized that specifically inhibiting those HDACs involved in cancer with Mocetinostat may restore normal cell function and reduce or inhibit tumour growth.
Innovators Monograph
You find simplified version here Mocetinostat
